Vitamin B12 deficiency

Signs, symptoms and complications

Vitamin B12 deficiency appears slowly and worsens over time, and can often be confused with other conditions. It may often go unrecognized, as the body becomes used to feeling unwell.

Vitamin B12 deficiency can lead to anemia, neurologic, and digestive dysfunctions. A mild deficiency may not cause any discernible symptoms, but at levels moderately lower than normal, a range of symptoms such as feeling tired, weak, lightheadedness, headaches, dizziness, rapid breathing, rapid heartbeat, cold hands and feet, low-grade fevers, tremor, cold intolerance, easy bruising and bleeding, pale skin, low blood pressure, sore tongue, upset stomach, loss of appetite, weight loss, constipation, diarrhea, severe joint pain, feeling abnormal sensations including numbness or tingling (pins and needles) to the fingers and toes, and tinnitus, may be experienced. A wide range of associated symptoms may include angular cheilitis, mouth ulcers, bleeding gums, hair loss and thinning, premature greying, a look of exhaustion and dark circles around the eyes, as well as brittle nails.

Severe vitamin B12 deficiency can damage nerve cells. Tissue deficiencies may negatively affect nerve cells, bone marrow, and the skin.

A further complication of severe deficiency is the neurological complex known as subacute combined degeneration of spinal cord. also myelosis funicularis, or funicular myelosis. This complex consists of the following symptoms:

1. Impaired perception of deep touch, pressure and vibration, loss of sense of touch, very annoying and persistent paresthesias
2. Ataxia of dorsal column type
3. Decrease or loss of deep muscle-tendon reflexes
4. Pathological reflexesBabinski, Rossolimo and others, also severe paresis.

The presence of peripheral sensory-motor symptoms or subacute combined degeneration of the spinal cord strongly suggests the presence of a B12 deficiency instead of folate deficiency. Methylmalonic acid, if not properly handled by B12, remains in the myelin sheath, causing fragility. Dementia and depression have been associated with this deficiency as well, possibly from the under-production of methionine because of the inability to convert homocysteine into this product. Methionine is a necessary cofactor in the production of several neurotransmitters. Each of those symptoms can occur either alone or with others.

Vitamin B12 is essential for the development of the brain. Its deficiency can cause neurodevelopmental problems, which can be partly reversible with early treatment. Only a small subset of dementia cases are reversible with vitamin B12 therapy. Tinnitus may be associated with vitamin B12 deficiency.

Vitamin B12 deficiency may accompany certain eating disorders or restrictive diets.

Pernicious anemia

Pernicious anemia is a disease caused by an autoimmune response that produces antibodies that attack the parietal cells in the stomach lining, preventing them from creating intrinsic factor needed for the absorption of vitamin B12. It occurs in only about 2-3% of the population over the age of 65. It is the main and most common cause of vitamin B12 deficiency anemia in developed countries, and is characterized by a triad of symptoms:

1. Anemia with bone marrow promegaloblastosis (megaloblastic anemia). This is due to the inhibition of DNA synthesis (specifically purines and thymidine).
2. Gastrointestinal symptoms: alteration in bowel motility, such as mild diarrhea or constipation, and loss of bladder or bowel control. These may be due to defective DNA synthesis inhibiting replication in a site with a high turnover of cells. This may also result from the autoimmune attack on parietal cells of the stomach. There is an association with "watermelon stomach" (GAVE) and pernicious anemia.
3. Neurological symptoms: Sensory or motor deficiencies (absent reflexes, diminished vibration or soft touch sensation), subacute combined degeneration of spinal cord, or seizures. Deficiency symptoms in children include developmental delay, regression, irritability, involuntary movements, and hypotonia.

In babies, neurological symptoms can occur from malnutrition or pernicious anemia in the mother. These include poor growth, apathy, having no desire for food, and developmental regression. While most symptoms resolve with supplementation, some developmental and cognitive problems may persist.

Metabolic risk in offspring

Vitamin B12 is a critical micronutrient essential for supporting the increasing metabolic demands of the foetus during pregnancy. B12 deficiency in pregnant women is increasingly common and has been shown to be associated with major maternal health implications, including increased obesity, higher body mass index (BMI), insulin resistance, gestational diabetes, and type 2 diabetes (T2D) in later life. A study in a pregnant white non-diabetic population in England, found that for every 1% increase in BMI, there was 0.6% decrease in circulating B12. Furthermore, an animal study in ewes demonstrated that a B12, folate and methionine restricted diet around conception, resulted in offspring with higher adiposity, blood pressure and insulin resistance which could be accounted for by altered DNA methylation patterns.

Both vitamin B12 and folate are involved in the one-carbon metabolism cycle. In this cycle, vitamin B12 is a necessary cofactor for methionine synthase, an enzyme involved in the methylation of homocysteine to methionine. DNA methylation is involved in the functioning of genes and is an essential epigenetic control mechanism in mammals. This methylation is dependent on methyl donors such as vitamin B12 from the diet. Vitamin B12 deficiency has the potential to influence methylation patterns in DNA, besides other epigenetic modulators such as micro (RNAs), leading to the altered expression of genes. Consequently, an altered gene expression can possibly mediate impaired foetal growth and the programming of non-communicable diseases.

Vitamin B12 and folate status during pregnancy is associated with the increasing risk of low birth weight, preterm birth, insulin resistance and obesity in the offspring. In addition it has been associated with adverse foetal and neonatal outcomes including neural tube defects (NTDs) The mother's B12 status can be important in determining the later health of the child, as shown in the Pune maternal Nutrition Study, conducted in India. In this study, children born to mothers with high folate concentrations and low vitamin B12 concentrations were found to have higher adiposity and insulin resistance at age 6. In the same study, over 60% of pregnant women were deficient in vitamin B12, which was considered to increase the risk of gestational and later diabetes in the mothers. Increased longitudinal cohort studies or randomised controlled trials are required to understand the mechanisms between vitamin B12 and metabolic outcomes, and to potentially offer interventions to improve maternal and offspring health.

Cardiometabolic disease outcomes

Multiple studies have explored the association between vitamin B12 and metabolic disease outcomes, such as obesity, insulin resistance and the development of cardiovascular disease. A long-term study where vitamin B12 was supplemented across a period of 10 years, led to lower levels of weight gain in overweight or obese individuals (p

There are several mechanisms which may explain the relationship between obesity and decreased vitamin B12 status. Vitamin B12 is a major dietary methyl donor, involved in the one-carbon cycle of metabolism and a recent genome-wide association (GWA) analysis showed that increased DNA methylation is associated with increased BMI in adults, consequently a deficiency of vitamin B12 may disrupt DNA methylation and increase non-communicable disease risk. Vitamin B12 is also a co-enzyme which converts methylmalonyl-CoA to succinyl-CoA in the one carbon cycle. If this reaction cannot occur, methylmalonyl-CoA levels elevate, inhibiting the rate-limiting enzyme of fatty acid oxidation (CPT1 – carnitine palmitoyl transferase), leading to lipogenesis and insulin resistance. Further to this, reduced vitamin B12 concentrations in the obese population is thought to result from repetitive short-term restrictive diets and increased vitamin B12 requirements secondary to increased growth and body surface area. It has also been hypothesised that low vitamin B12 concentrations in obese individuals are a result of wrong feeding habits, where individuals consume a diet low in micronutrient density. Finally, vitamin B12 is involved in the production of red blood cells, and vitamin B12 deficiency can result in anemia, which causes fatigue and the lack of motivation to exercise.

The investigation into the relationship between cardiovascular disease and vitamin B12 has been limited, and there is still controversy as to whether primary intervention with vitamin B12 will lower cardiovascular disease. Deficiency of vitamin B12 can impair the remethylation of homocysteine in the methionine cycle, and result in raised homocysteine levels. There is much evidence linking elevated homocysteine concentrations with an increased risk of cardiovascular disease, and homocysteine lowering treatments have led to improvements in cardiovascular reactivity and coagulation factors. In adults with metabolic syndrome, individuals with low levels of vitamin B12 had higher levels of homocysteine compared to healthy subjects. It is thus possible that vitamin B12 deficiency enhances the risk of developing cardiovascular disease in individuals who are obese. Alternatively, low levels of vitamin B12 may increase the levels of proinflammatory proteins which may induce ischaemic stroke.

It is important to screen vitamin B12 deficiency in obese individuals, due to its importance in energy metabolism, and relationship with homocysteine and its potential to modulate weight gain. More studies are needed to test for the causality of vitamin B12 and obesity using genetic markers. A few studies have also reported no deficiency of vitamin B12 in obese individuals. Finally, a recent literature review conducted over 19 studies, found no evidence of an inverse association between BMI and circulating vitamin B12.

Previous clinical and population-based studies have indicated that vitamin B12 deficiency is prevalent amongst adults with type 2 diabetes. Kaya et al., conducted a study in women with polycystic ovary syndrome, and found that obese women with insulin resistance had lower vitamin B12 concentrations compared to those without insulin resistance. Similarly, in a study conducted in European adolescents, there was an association between high adiposity and higher insulin sensitivity with vitamin B12 concentrations. Individuals with a higher fat mass index and higher insulin sensitivity (high Homeostatic Model Assessment [HOMA] index) had lower plasma vitamin B12 concentrations. Furthermore, a recent study conducted in India reported that mean levels of vitamin B12 decreased with increasing levels of glucose tolerance e.g. individuals with type 2 diabetes had the lowest values of vitamin B12, followed by individuals with pre-diabetes and normal glucose tolerance, respectively. However, B12 levels of middle aged-women with and without metabolic syndrome showed no difference in vitamin B12 levels between those with insulin resistance (IR) and those without. It is believed that malabsorption of vitamin B12 in diabetic patients, is due to individuals taking metformin therapy (an insulin sensitizer used for treating type 2 diabetes). Furthermore, obese individuals with type 2 diabetes are likely to develop gastroesophageal reflux disease, and take proton pump inhibitors, which further increased the risk of vitamin B12 deficiency.

A literature review conducted in 2011 over seven studies, found that there was limited evidence to show that low vitamin B12 status increased the risk of cardiovascular disease and diabetes. However, the review did not identify any associations between vitamin B12 and cardiovascular disease in the remaining four studies. Currently, no data supports vitamin B12 supplementation on reducing the risk of cardiovascular disease. In a dose-response meta-analysis of five prospective cohort studies, it was reported that the risk of coronary heart disease (CHD) did not change substantially with increasing dietary vitamin B12 intake. Of these five studies, three of the studies stated a non-significant positive association and two of the studies demonstrated an inverse association between vitamin B12 supplementation and coronary heart disease (only one of the studies was significant).

Anemia

Vitamin B12 deficiency is one of the main causes of anemia. In countries where B12 deficiency is common, it is generally assumed that there is a greater risk of developing anemia. However, the overall contribution of vitamin B12 deficiency to the global incidence of anemia may not be significant, except in elderly individuals, vegetarians, cases of malabsorption and some genetic disorders. Anemia is defined as a condition in which there are not enough red blood cells, as the tissues and organs of the body do not get enough oxygen. Megaloblastic anemia caused by vitamin B12 deficiency is characterized by red blood cells that are larger than normal and are unable to deliver oxygen to the body's organs. The clinical case indicates an altered synthesis of DNA, in which vitamin B12 is essential for the production and maturation of red blood cells in the bone marrow. Adult patients often report to medical attention symptoms related to anemia, such as feeling tired and weak, breathlessness, exercise intolerance, feeling faint, headaches, paleness, dry lips and a disturbance of taste.

Pernicious anemia is the most common cause of vitamin B12 deficiency anemia in adults, which results from malabsorption of vitamin B12 due to a lack or loss of intrinsic factor. There are relatively few studies which have assessed the impact of haematological measures in response to B12 supplementation. One study in 184 premature infants, reported that individuals given monthly vitamin B12 injections (100 μg) or taking supplements of vitamin B12 and folic acid (100 μg/day), had higher haemoglobin concentrations after 10–12 weeks, compared to those only taking folic acid or those taking no vitamin B12 injections.

Aging

In the elderly, vitamin B12 deficiency has been associated with the development of macular degeneration, and the risk of frailty. Macular degeneration is the leading cause of severe, irreversible vision loss in older adults. Several risk factors have been linked to macular degeneration, including family history, genetics, hypercholesterolemia, hypertension, sunlight exposure and lifestyle (smoking and diet). It has been shown that daily supplementation of vitamin B12, B6 and folate over a period of seven years can reduce the risk of age-related macular degeneration by 34% in women with increased risk of vascular disease (n=5,204). However, another study failed to find an association between age-related macular degeneration and vitamin B12 status in a sample of 3,828 individuals representative of the non-institutionalized US population.

Frailty is a geriatric condition which is characterized by diminished endurance, strength, and reduced physiological function that increases an individual's risk of mortality and impairs an individual from fulfilling an independent lifestyle. Frailty is associated with an increased vulnerability to fractures, falls from heights, reduced cognitive function and more frequent hospitalisation. The worldwide prevalence of frailty within the geriatric population is 13.9%, therefore there is an urgent need to eliminate any risk factors associated with frailty. Poor vitamin B status has been shown to be associated with an increased risk of frailty. Two cross sectional studies have reported that deficiencies of vitamin B12 were associated with the length of hospital stay, as observed by serum vitamin B12 concentrations and methylmalonic acid (MMA) concentrations. Furthermore, another study of elderly women, found that certain genetic variants associated with vitamin B12 status (tanscobalamin II) may contribute to reduced energy metabolism, consequently contributing to frailty. Given that there are limited studies assessing the relationship between vitamin B12 and frailty status, more longitudinal studies are needed to clarify the relationship.

Neurological decline

Severe vitamin B12 deficiency is associated with subacute combined degeneration of the spinal cord, which involves demyelination of the posterior and lateral columns of the spinal cord. Symptoms include memory and cognitive impairment, sensory loss, motor disturbances, personality changes, disorientation, irritability, dementia, loss of posterior column functions and disturbances in proprioception. In advanced stages of vitamin B12 deficiency, cases of psychosis, paranoia and severe depression have been observed, which may lead to permanent disability if left untreated. Studies have shown the rapid reversal of the neurological symptoms of vitamin B12 deficiency, after treatment with high-dose of vitamin B12 supplementation; suggesting the importance of prompt treatment in reversing neurological manifestations.

Cognitive decline

Elderly individuals are currently assessed on vitamin B12 status during the screening process for dementia. Studies investigating the association between vitamin B12 concentrations and cognitive status have produced inconclusive results. It has been shown that elevated MMA concentrations are associated with decreased cognitive decline and Alzheimer's disease. In addition, low vitamin B12 and folate intakes have shown associations with hyperhomocysteinemia, which is associated with cerebrovascular disease, cognitive decline and an increased risk of dementia in prospective studies.

There are limited intervention studies which have investigated the effect of supplementation of vitamin B12 and cognitive function. A Cochrane review, analysing two studies, found no effect of vitamin B12 supplementation on the cognitive scores of older adults. A recent longitudinal study in elderly individuals, found that individuals had a higher risk of brain volume loss over a 5-year period, if they had lower vitamin B12 and holoTC levels and higher plasma tHcy and MMA levels. More intervention studies are needed to determine the modifiable effects of vitamin B12 supplementation on cognition on people who are not deficient.

Osteoporosis

There has been growing interest on the effect of low serum vitamin B12 concentrations on bone health. Studies have found a connection between elevated plasma tHcy and an increased risk of bone fractures, but is unknown whether this is related to the increased levels of tHcy or to vitamin B12 levels (which are involved in homocysteine metabolism). Results from the third NHANES conducted in the United States, found that individuals had significantly lower bone mass density (BMD) and higher osteoporosis rates with each higher quartile of serum MMA (n= 737 men and 813 women). Given that poor bone mineralization has been found in individuals with pernicious anemia, it is possible that vitamin B12 deficiency is causally related to poor bone health.

Randomized intervention trials investigating the association of vitamin B12 supplementation and bone health have yielded mixed results. One study conducted on osteoporotic risk patients with hyperhomocysteinemia found positive effects between supplementation of B vitamins on BMD. However, no improvement in BMD was observed in a group of healthy older people. Further, controlled trials are needed to confirm the impact and mechanisms vitamin B12 deficiency has on bone mineralization.

Causes

Vitamin B12 deficiency can be caused by impaired absorption, inadequate dietary intake, or increased requirements. Impaired absorption explains most cases of vitamin B12 deficiency, but it can also result from other factors.

Impaired absorption

• Lack of intrinsic factor: intrinsic factor is a protein produced by parietal cells in the stomach, and needed in the ileum for the absorption of vitamin B12. Lack of intrinsic factor is most commonly due to an autoimmune attack on the cells that create it in the stomach, and this condition takes the name "pernicious anemia". PA may be considered as an end stage of autoimmune atrophic gastritis, a disease characterised by stomach atrophy and the presence of antibodies to parietal cells and intrinsic factor. It can also occur following the surgical removal of all or part of the stomach or small intestine; from an inherited disorder or illnesses that damage the stomach lining. Gastric surgeries that involve the removal of all or part of the stomach, such as Roux-en-Y gastric bypass or surgical removal of the small bowel results in short bowel syndrome.
• Digestive conditions: conditions that can give rise to impaired absorption of vitamin B12 may include achlorhydria, Crohn's disease, coeliac disease, chronic pancreatitis, and some intestinal parasites. Forms of achlorhydria (including that artificially induced by drugs such as proton pump inhibitors and histamine 2 receptor antagonists) can cause B12 malabsorption from foods, since acid is needed to split B12 from food proteins and salivary binding proteins. This process is thought to be the most common cause of low B12 in the elderly, who often have some degree of achlorhydria without being formally low in intrinsic factor. This process does not affect absorption of small amounts of B12 in supplements such as multivitamins, since it is not bound to proteins, as is the B12 in foods. Some infections such as giardiasis, and diphyllobothriasis caused by parasites can also cause malabsorption. Impaired absorption can also result from blind loop syndrome where an overpopulation of bacteria in the small intestine absorb the vitamin. B12 deficiency caused by Helicobacter pylori was positively correlated with CagA positivity and gastric inflammatory activity, rather than gastric atrophy.
• Medications: long-term use of certain medications can result in poor absorption of dietary vitamin B12. These include medications to treat heartburn, and metformin to treat diabetes.
• A genetic disorder, transcobalamin II deficiency, or Imerslund–Gräsbeck syndrome can be a cause.
• Nitrous oxide exposure, and recreational use.

Inadequate intake

Vitamin B12 cannot be produced by the human body, and must be obtained from the diet. The body normally gets enough vitamin B12 from the consumption of foods from animal sources. Inadequate dietary intake of animal products such as eggs, meat, milk, fish, fowl (and some types of edible algae) can result in a deficiency state. Vegans, and to a lesser degree vegetarians, are at risk for B12 deficiency if they do not consume either a dietary supplement or vitamin-fortified foods. Children are at a higher risk for B12 deficiency due to inadequate dietary intake, as they have fewer vitamin stores and a relatively larger vitamin need per calorie of food intake.

Increased need

Increased needs by the body can occur due to AIDS and hemolysis (the breakdown of red blood cells), which stimulates increased red cell production.

Mechanism

Physiology

The total amount of vitamin B12 stored in the body is between two and five milligrams in adults. Approximately 50% is stored in the liver, but approximately 0.1% is lost each day, due to secretions into the gutnot all of the vitamin in the gut is reabsorbed. While bile is the main vehicle for B12 excretion, most of this is recycled via enterohepatic circulation. Due to the extreme efficiency of this mechanism, the liver can store three to five years worth of vitamin B12 under normal conditions and functioning. However, the rate at which B12 levels may change when dietary intake is low depends on the balance between several variables.

The human physiology of active vitamin B12 absorption from food is complex. When foods containing B12 are eaten, the vitamin is usually bound to protein and is released by proteases released by the pancreas in the small intestine. Following its release, most B12 is absorbed in the ileum, the last part of the small intestine, after binding to a protein known as intrinsic factor.

Pathophysiology

Vitamin B12 deficiency causes particular changes to the metabolism of two clinically relevant substances in humans:

1. Homocysteine (homocysteine to methionine, catalysed by methionine synthase) leading to hyperhomocysteinemia
2. Methylmalonic acid (methylmalonyl-CoA to succinyl-CoA, of which methylmalonyl-CoA is made from methylmalonic acid in a preceding reaction) Methionine is activated to S-adenosyl methionine, which aids in purine and thymidine synthesis, myelin production, protein/neurotransmitters/fatty acid/phospholipid production and DNA methylation. 5-methyl tetrahydrofolate provides a methyl group, which is released to the reaction with homocysteine, resulting in methionine. This reaction requires cobalamin as a cofactor. The creation of 5-methyl tetrahydrofolate is an irreversible reaction. If B12 is absent, the forward reaction of homocysteine to methionine does not occur, homocysteine concentrations increase, and the replenishment of tetrahydrofolate stops. Because B12 and folate are involved in the metabolism of homocysteine, hyperhomocysteinuria is a non-specific marker of deficiency. Methylmalonic acid is used as a test of B12 deficiency, but has a low specificity.

Nervous system

Early changes include a spongiform state of neural tissue, along with edema of fibers and deficiency of tissue. The myelin decays, along with axial fiber. In later phases, fibric sclerosis of nervous tissues occurs. Those changes occur in dorsal parts of the spinal cord and to pyramidal tracts in lateral cords and are called subacute combined degeneration of spinal cord. Pathological changes can be noticed as well in the posterior roots of the cord and, to lesser extent, in peripheral nerves.

In the brain itself, changes are less severe: They occur as small sources of nervous fibers decay and accumulation of astrocytes, usually subcortically located, and also round hemorrhages with a torus of glial cells.

MRI of the brain may show periventricular white matter abnormalities. MRI of the spinal cord may show linear hyperintensity in the posterior portion of the cervical tract of the spinal cord, with selective involvement of the posterior columns.

Diagnosis

A diagnosis of vitamin B12 deficiency is determined by blood levels lower than 200 or 250 picograms per ml (148 or 185 picomoles per liter). Measurement of blood methylmalonic acid (MMA), a vitamin B12-associated metabolite, is a commonly used biomarker. There is no gold standard assay to confirm a vitamin B12 deficiency.

Blood tests may show low levels of vitamin B12, elevated levels of methylmalonic acid or homocysteine, and a routine complete blood counts may shows anemia with an elevated mean cell volume. The presence of antibodies to gastric parietal cells and intrinsic factor may indicate pernicious anemia.

Deficiency can develop without anemia or within normal vitamin B12 levels, leading to a methylmalonic acid or homocysteine assay. In some cases, a peripheral blood smear may be used; which may allow to show macrocytes and hypersegmented polymorphonuclear leukocytes. Neuropsychiatric symptoms can precede hematological signs and are often the presenting manifestation of B12 deficiency. Anemia can be prevented or masked by folic acid in which activate tetrahydrofolate (THF) needed for DNA synthesis.

However, elevated methylmalonic acid levels may also be related to metabolic disorders such as methylmalonic acidemia. If elevated methylmalonic acid levels are further accompanied by elevated malonic acid levels, this may be indicative of combined malonic and methylmalonic aciduria (CMAMMA).

If nervous system damage is present and blood testing is inconclusive, a lumbar puncture to measure cerebrospinal fluid B-12 levels may be done. On bone marrow aspiration or biopsy, megaloblasts are seen.

The Schilling test was a radio-isotope method, now outdated, of testing for low vitamin B12.

Serum levels

An isolated serum vitamin B12 level has poor sensitivity and specificity for reliably detecting the deficiency; it can be falsely low in some individuals, and falsely normal or high in deficient individuals. Vitamin B12 deficiency can be determined, but not always. This means it measures forms of vitamin B12 that are "active" and can be used by the body, as well as the "inactive" forms, which cannot. The deficiency can develop within normal levels, so clinical symptoms should be taken into account when a diagnosis is made. Normal blood levels are considered to be at least above 300 pg/mL in adults. Some researchers have suggested that current standards for vitamin B12 levels are too low.

Treatment

Treatment should take into account the cause and severity of the condition.

There is risk that folic acid administered to those with untreated B12 deficiency may mask anemia without solving the issue at hand in which, if left untreated, can cause lasting serious side effects that affect the nervous system and brain.

Measuring vitamin B12 values during or after treatment, in order to measure the effectiveness of treatment, is useless.

Epidemiology

Vitamin B12 deficiency is common and occurs worldwide. In the US and UK, around 6 percent of the general population have the deficiency; in those over the age of sixty, around 20 percent are deficient. In under-developed countries, the rates are even higher: across Latin America 40 percent are deficient; in some parts of Africa, 70 percent; and in some parts of India, 70 to 80 percent.

According to the World Health Organization (WHO), vitamin B12 deficiency may be considered a global public health problem affecting millions of individuals. However, the incidence and prevalence of vitamin B12 deficiency worldwide is unknown due to the limited population-based data available (see table below).

Developed countries such as the United States, Germany and the United Kingdom have relatively constant mean vitamin B12 concentrations. The data from the National Health and Nutrition Examination Survey (NHANES) reported the prevalence of serum vitamin B12 concentrations in the United States population between 1999 and 2002. Serum vitamin B12 concentrations of 12 concentration below the cut-off.

Furthermore, ≈ 14–16% of adults and 20% of elderly individuals showed evidence of marginal vitamin B12 depletion (serum vitamin B12: 148–221 pmol/L). In the United Kingdom, a National Diet and Nutrition Survey (NDNS) was conducted in adults aged between 19 and 64 years in 2000–2001 and in elderly individuals (≥ 65 years) in 1994–95. Six percent of men (n = 632) and 10% of women (n = 667) had low serum vitamin B12 concentrations, defined as 12 concentrations 12 deficiency increased substantially in the elderly, where 31% of the elderly had vitamin B12 levels below 130 pmol/L. In the most recent NDNS survey conducted between 2008 and 2011, serum vitamin B12 was measured in 549 adults. The mean serum vitamin B12 concentration for men (19–64 years) was 308 pmol/L, of which 0.9% of men had low serum B12 concentrations 12 concentration was slightly lower than men (298 pmol/L), with 3.3% having low vitamin B12 concentrations 12 concentrations of

Few studies have reported vitamin B12 status on a national level in non-Western countries. Of these reported studies, vitamin B12 deficiency was prevalent among school-aged children in Venezuela (11.4%), children aged 1–6 years in Mexico (7.7%), women of reproductive age in Vietnam (11.7%), pregnant women in Venezuela (61.34%) and in the elderly population ( 65 years) in New Zealand (12%). Currently, there are no nationally representative surveys for any African or South Asian countries. However, the very few surveys which have investigated vitamin B12 deficiency in these countries have been based on local or district level data. These surveys have reported a high prevalence of vitamin B12 deficiency (12 deficiency.

Derived from Table 2 available on

History

Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy. During the 1920s, George Whipple discovered that ingesting large amounts of liver seemed to most rapidly cure the anemia of blood loss in dogs, and hypothesized that eating liver might treat pernicious anemia. Edwin Cohn prepared a liver extract that was 50 to 100 times more potent in treating pernicious anemia than the natural liver products. William Castle demonstrated that gastric juice contained an "intrinsic factor" which when combined with meat ingestion resulted in absorption of the vitamin in this condition. In 1934, George Whipple shared the 1934 Nobel Prize in Physiology or Medicine with William P. Murphy and George Minot for discovery of an effective treatment for pernicious anemia using liver concentrate, later found to contain a large amount of vitamin B12.

Other animals

Ruminants, such as cattle and sheep, absorb B12 synthesized by their gut bacteria. Sufficient amounts of cobalt and copper need to be consumed for this B12 synthesis to occur.

In the early 20th century, during the development for farming of the North Island Volcanic Plateau of New Zealand, cattle had what was termed "bush sickness". It was discovered in 1934 that the volcanic soils lacked the cobalt salts essential for synthesis of vitamin B12 by their gut bacteria.

References

References

1. (September 2014). "Vitamin B12 deficiency". BMJ.
2. (March 2018). "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency". The Cochrane Database of Systematic Reviews.
3. (2026). "Vitamin B12: Deficiency". Micronutrient Information Center, Linus Pauling Institute, Oregon State University.
4. (2011). "Vitamins in the prevention of human diseases". Walter de Gruyter.
5. (20 February 2023). "Vitamin B12 or folate deficiency anaemia – Complications". National Health Service, UK Government.
6. (July 2018). "Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications". Advances in Nutrition.
7. (2022-05-14). "Further cases of false normal B₁₂ assays – intrinsic factor antibody interference a possible mechanism?". BMJ.
8. (2008). "Clinical neurology". Manson.
9. (2012). "The 5-minute pediatric consult". Wolters Kluwer Health/Lippincott Williams & Wilkins.
10. (September 2017). "Vitamin B12 Deficiency: Recognition and Management". American Family Physician.
11. (May 2016). "Oral manifestations in vitamin B12 deficiency patients with or without history of gastrectomy". BMC Oral Health.
12. (October 2013). "Undetected vitamin B12 deficiency due to false normal assay results". Blood Transfusion = Trasfusione del Sangue.
13. "Vitamin B₁₂ Deficiency – Disorders of Nutrition".
14. (2021-07-28). "Vitamin B₁₂ Deficiency: Causes, Symptoms, and Treatment".
15. (2014). "Neurologic aspects of systemic disease".
16. "Vitamin B₁₂ Deficiency Anemia {{!}} Michigan Medicine".
17. "Vitamin B₁₂ or folate deficiency anaemia".
18. "Articles".
19. (March 2000). "Images in clinical medicine. Ischemic retinopathy caused by severe megaloblastic anemia". The New England Journal of Medicine.
20. Sahu, Prashant. (2022). "Neuropsychiatric manifestations in vitamin B12 deficiency". Vitamins and Hormones.
21. (2022). "StatPearls". StatPearls Publishing.
22. (January 21, 2015). "Subacute combined degeneration of the cord (funicular myelosis) {{!}} Radiology Case {{!}} Radiopaedia.org".
23. (2015). "[Neurological complications due to vitamin deficiencies after bariatric surgery]". Terapevticheskii Arkhiv.
24. (2021). "Vitamin B12 deficiency: case report and review of literature". The Pan African Medical Journal.
25. (April 2012). "Cognitive impairment and vitamin B12: a review". International Psychogeriatrics.
26. (2014). "Handbook of vitamins". CRC Press.
27. (June 2002). "Dietary vitamin B12 deficiency in an adolescent white boy". Journal of Clinical Pathology.
28. "Watermelon stomach {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
29. (2015-08-19). "Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population". PLOS ONE.
30. (January 2017). "Erratum for Sukumar N et al. Prevalence of vitamin B-12 insufficiency during pregnancy and its effect on offspring birth weight: a systematic review and meta-analysis. Am J Clin Nutr 2016; 103:1232–1251". The American Journal of Clinical Nutrition.
31. (January 2008). "Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study". Diabetologia.
32. (November 2009). "Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes". Diabetologia.
33. (December 2007). "DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status". Proceedings of the National Academy of Sciences of the United States of America.
34. (March 2014). "The role of the one-carbon cycle in the developmental origins of Type 2 diabetes and obesity". Diabetic Medicine.
35. (February 2016). "Vitamin B12 and folate status in early pregnancy and cardiometabolic risk factors in the offspring at age 5–6 years: findings from the ABCD multi-ethnic birth cohort". BJOG.
36. (November 2017). "Low Vitamin B12 in Pregnancy Is Associated With Adipose-Derived Circulating miRs Targeting PPARγ and Insulin Resistance". The Journal of Clinical Endocrinology and Metabolism.
37. (April 2015). "Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome". Nutrients.
38. (June 2012). "Fetal programming: maternal nutrition and role of one-carbon metabolism". Reviews in Endocrine & Metabolic Disorders.
39. (February 2017). "Associations of Maternal Vitamin B12 Concentration in Pregnancy With the Risks of Preterm Birth and Low Birth Weight: A Systematic Review and Meta-Analysis of Individual Participant Data". American Journal of Epidemiology.
40. (March 2009). "Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification". Pediatrics.
41. (May 2007). "Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population". Epidemiology.
42. (November 1993). "Maternal plasma folate and vitamin B₁₂ are independent risk factors for neural tube defects". QJM: An International Journal of Medicine.
43. (October 2018). "Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity". Clinical Nutrition.
44. (September 2006). "Obese children and adolescents: a risk group for low vitamin B12 concentration". Archives of Pediatrics & Adolescent Medicine.
45. (October 2011). "Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey". The American Journal of Clinical Nutrition.
46. (May 2006). "Vitamin and trace mineral levels after laparoscopic gastric bypass". Obesity Surgery.
47. (October 2005). "Dietary supplements and weight control in a middle-age population". Journal of Alternative and Complementary Medicine.
48. (June 2014). "DNA methylation and body-mass index: a genome-wide analysis". Lancet.
49. (September 2014). "Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes". Cardiovascular Diabetology.
50. Wall, С., Food and Nutrition Guidelines for Healthy Adolescents. Ministry of Health. Wellington, New Zealand, 1998.
51. (October 2017). "Association between vitamin deficiency and metabolic disorders related to obesity". Critical Reviews in Food Science and Nutrition.
52. (June 2014). "The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease". Cardiovascular Therapeutics.
53. (July 1999). "Homocysteine metabolism". Annual Review of Nutrition.
54. (November 2002). "Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis". BMJ.
55. (October 2004). "Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia". European Journal of Endocrinology.
56. (November 2005). "Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome". Heart and Vessels.
57. (October 2005). "Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis". JAMA.
58. (August 2008). "Associations of proinflammatory cytokines with the risk of recurrent stroke". Stroke.
59. (November 2018). "A systematic review of the vitamin B12, folate and homocysteine triad across body mass index". Obesity Reviews.
60. (May 2008). "Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study". European Journal of Clinical Nutrition.
61. (August 2002). "Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity". The Israel Medical Association Journal.
62. (May 2006). "Elevated plasma homocysteine in obese schoolchildren with early atherosclerosis". European Journal of Pediatrics.
63. (February 2008). "Vitamin status in morbidly obese patients: a cross-sectional study". The American Journal of Clinical Nutrition.
64. (2016-06-03). "Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study". Sao Paulo Medical Journal = Revista Paulista de Medicina.
65. (December 2015). "Vitamin B12 deficiency among adult diabetic patients in Uganda: relation to glycaemic control and haemoglobin concentration". Journal of Diabetes and Metabolic Disorders.
66. (November 2009). "Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS". Reproductive Biomedicine Online.
67. (June 2017). "[Associations between insulin resistance and three B-vitamins in European adolescents: the HELENA study]". Nutricion Hospitalaria.
68. (December 2018). "Prevalence of vitamin B₁₂ deficiency in South Indians with different grades of glucose tolerance". Acta Diabetologica.
69. (2012). "Homocysteine levels in morbidly obese patients: its association with waist circumference and insulin resistance". Clinical Hemorheology and Microcirculation.
70. (February 2012). "Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999–2006". Diabetes Care.
71. (August 2005). "Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications". Annals of Internal Medicine.
72. (2019-09-08). "Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies". Critical Reviews in Food Science and Nutrition.
73. (June 2008). "A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate into a comparable prevalence of anemia". Food and Nutrition Bulletin.
74. (February 1968). "Folic acid and vitamin B12 supplementation during pregnancy in a population subsisting on a suboptimal diet". The Journal of Obstetrics and Gynaecology of the British Commonwealth.
75. (October 2003). "Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study". Ophthalmic Epidemiology.
76. (December 2016). "Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors". Eye and Vision.
77. (August 2017). "Recent developments in age-related macular degeneration: a review". Clinical Interventions in Aging.
78. (May 2006). "Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration". Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie.
79. (February 2007). "Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study". American Journal of Ophthalmology.
80. (February 2009). "Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study". Archives of Internal Medicine.
81. (October 2002). "Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey". The American Journal of Clinical Nutrition.
82. (June 2013). "Frailty consensus: a call to action". Journal of the American Medical Directors Association.
83. (December 2016). "Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis". Journal of the American Medical Directors Association.
84. (November 2016). "Inflammation and frailty in the elderly: A systematic review and meta-analysis". Ageing Research Reviews.
85. (June 2011). "B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients". The Journal of Nutrition, Health & Aging.
86. (May 2008). "Markers of B-vitamin deficiency and frailty in older women". The Journal of Nutrition, Health & Aging.
87. (September 2014). "Vitamin B12 deficiency". BMJ.
88. (January 2010). "Advances in the understanding of cobalamin assimilation and metabolism". British Journal of Haematology.
89. (December 2013). "Neuroenhancement with vitamin B12-underestimated neurological significance". Nutrients.
90. Holmes, J. MacDonald. (1956-12-15). "Cerebral Manifestations of Vitamin-B12 Deficiency". Br Med J.
91. (September 2015). "B12 deficiency with neurological manifestations in the absence of anaemia". BMC Research Notes.
92. (June 2008). "Effects of folate and vitamin B12 on cognitive function in adults and the elderly". Food and Nutrition Bulletin.
93. (February 2009). "Vitamin B-12 and cognition in the elderly". The American Journal of Clinical Nutrition.
94. (2005-04-14). "Elevated methylmalonic acid is related to cognitive impairement in older adults enrolled in an elderly nutrition program". Journal of Nutrition for the Elderly.
95. (November 2007). "Homocysteine, vitamins, and vascular disease prevention". The American Journal of Clinical Nutrition.
96. (2003-07-21). "Vitamin B12 for cognition". John Wiley & Sons, Ltd.
97. (September 2008). "Vitamin B12 status and rate of brain volume loss in community-dwelling elderly". Neurology.
98. (June 2005). "Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people". Journal of Bone and Mineral Research.
99. (January 2005). "Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study". Journal of Bone and Mineral Research.
100. (2007-01-01). "The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review". Clinical Chemistry and Laboratory Medicine.
101. (August 2005). "Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans". Bone.
102. (2007-01-01). "The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial". Clinical Chemistry and Laboratory Medicine.
103. (February 2007). "Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial". The American Journal of Clinical Nutrition.
104. (March 2010). "Considering the case for vitamin B12 fortification of flour". Food and Nutrition Bulletin.
105. (June 2011). "Pernicious anemia - genetic insights". Autoimmunity Reviews.
106. (June 2017). "Vitamin B₁₂ deficiency". Nature Reviews. Disease Primers.
107. (March 2015). "Advances in mechanisms, diagnosis, and treatment of pernicious anemia". Discovery Medicine.
108. (2021). "Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis". Journal of Translational Autoimmunity.
109. "Blind loop syndrome: MedlinePlus Medical Encyclopedia".
110. (1999). "Vitamin B12 deficiency in the elderly". Annual Review of Nutrition.
111. (December 2013). "Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency". JAMA.
112. (2 March 2021). "Illness and Symptoms {{!}} Giardia {{!}} Parasites {{!}} CDC".
113. (2019). "The Relation of Cytotoxin-Associated Gene-A Seropositivity with Vitamin B12 Deficiency in ''Helicobacter pylori''-Positive Patients". BioMed Research International.
114. (October 2006). "Risk factors of vitamin B(12) deficiency in patients receiving metformin". Archives of Internal Medicine.
115. (July 1982). "Effect of chronic ranitidine treatment on secretion of intrinsic factor". British Medical Journal.
116. (May 1981). "Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats". The Journal of Clinical Investigation.
117. (November 2005). "Algae acquire vitamin B12 through a symbiotic relationship with bacteria". Nature.
118. (January 2001). "Vitamin B12 deficiency in children and adolescents". The Journal of Pediatrics.
119. (2010). "Biochemistry". J. Wiley & Sons.
120. (2013). "Interrelations between Essential Metal Ions and Human Diseases". Springer.
121. (1985). "Vitamin B12-folate interrelationships". Annual Review of Nutrition.
122. "Vitamin B₁₂ / Pathophysiology Text". LifeSave.org.
123. (November 1984). "Is there a "gold standard" for human serum vitamin B12 assay?". The Journal of Laboratory and Clinical Medicine.
124. (August 2014). "Guidelines for the diagnosis and treatment of cobalamin and folate disorders". Wiley.
125. (June 1988). "Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis". The New England Journal of Medicine.
126. (2016). "Nelson textbook of pediatrics: get full access and more at ExpertConsult.com". Elsevier, Saunders.
127. (2016). "A New Approach for Fast Metabolic Diagnostics in CMAMMA". Springer Berlin Heidelberg.
128. (August 2006). "Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay". BMJ.
129. "What is the role of bone marrow aspiration in the diagnosis of megaloblastic anemia?".
130. (1988). "Schilling test: physiologic basis for and use as a diagnostic test". Critical Reviews in Clinical Laboratory Sciences.
131. (2025). "Pernicious Anemia". StatPearls Publishing.
132. (2017-10-20). "Vitamin B12 or folate deficiency anaemia – Diagnosis".
133. (October 1996). "Are U.S. lower normal B12 limits too low?". Journal of the American Geriatrics Society.
134. (2008-10-08). "Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people". The Cochrane Database of Systematic Reviews.
135. "Diagnosis and treatment pitfalls – B12 institute".
136. (June 2008). "Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies". Food and Nutrition Bulletin.
137. (2004-07-14). "Vitamin B12 deficiency as a worldwide problem". Annual Review of Nutrition.
138. (September 2007). "Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004". The American Journal of Clinical Nutrition.
139. (August 2005). "Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000". The American Journal of Clinical Nutrition.
140. (2004). "National Diet and Nutrition Survey: Adults Aged 19 to 64 Years". The Stationery Office.
141. (June 1998). "The National Diet and Nutrition Survey: people aged 65 years and over". Nutrition & Food Science.
142. (2011). "National Diet and Nutrition Survey: Headline Results from Years 1, 2 and 3 (combined) of the Rolling Programme 2008/09 – 2010/11.".
143. (December 1999). "[Folic acid intake of women in childbearing age]". Gesundheitswesen.
144. (June 2008). "Review of the magnitude of folate and vitamin B12 deficiencies worldwide". Food and Nutrition Bulletin.
145. (September 2005). "High prevalence of folic acid and vitamin B12 deficiencies in infants, children, adolescents and pregnant women in Venezuela". European Journal of Clinical Nutrition.
146. (April 2012). "Prevalence of folate and vitamin B12 deficiency in Mexican children aged 1 to 6 years in a population-based survey". Salud Publica de Mexico.
147. (2012-04-17). "Micronutrient deficits are still public health issues among women and young children in Vietnam". PLOS ONE.
148. (February 2005). "Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders". European Journal of Clinical Nutrition.
149. (November 2007). "Cobalamin and folate status in infants and young children in a low-to-middle income community in India". The American Journal of Clinical Nutrition.
150. (August 2001). "Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians". The American Journal of Clinical Nutrition.
151. (November 2003). "Kenyan school children have multiple micronutrient deficiencies, but increased plasma vitamin B-12 is the only detectable micronutrient response to meat or milk supplementation". The Journal of Nutrition.
152. (2018). "Advances in Food and Nutrition Research". Academic Press.
153. (2014). "Wintrobe's Clinical Hematology Thirteenth Edition". Wolters Kluwer/Lippincott Williams & Wilkins.
154. "George H. Whipple – Biographical".
155. [https://www.nobelprize.org/nobel_prizes/medicine/laureates/1934/ The Nobel Prize in Physiology or Medicine 1934], ''Nobelprize.org'', Nobel Media AB 2014. Retrieved December 2, 2015.
156. (2008). "Vitamins in Animal and Human Nutrition.". John Wiley & Sons.
157. "Soils". Waikato University.
158. "Hedley Ralph Marston 1900–1965". Australian Academy of Science.